Impaired lymphocyte calcium metabolism in end-stage renal disease: Enhanced influx, decreased efflux, and reduced response to mitogen

Journal of Laboratory and Clinical Medicine

Volumn 133, Issue 4, 1999, Pages 391-400

  Ori, Y ^a,b   Korzets, A ^a,b   Malachi, T ^a,b   Gafter, U ^a,b   Breitbart, H ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033117580     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(99)90071-9     Document Type: Article

References (49)

1. 1. Gafter U, Malachi T, Barak H, Djaldetti M, Levi J. Red blood cell calcium homeostasis in patients with end-stage renal disease. J Lab Clin Med 1989;114:222-31.
2. 2. Gafter U, Malachi T, Barak H, Levi J. Red blood cell calcium level in chronic renal failure: effect of continuous ambulatory peritoneal dialysis. J Lab Clin Med 1990;116:386-92.
3. 3. Alexiewicz JM, Klinger M, Pitts TO, Gaciong Z, Linker-Israeli M, Massry SG. Parathyroid hormone inhibits B cell proliferation: implications in chronic renal failure. J Am Soc Nephrol 1990;1:236-44.
4. 4. Alexiewicz JM, Gaciong Z, Klinger M, Linker-Israeli M, Pitts TO, Massry SG. Evidence for impaired T cell function in hemodialysis patients: potential role for secondary hyperparathyroidism. Am J Nephrol 1990;10:495-501.
5. 5. Alexiewicz JM, Smogorzewski M, Fadda GZ, Massry SG. Impaired phagocytosis in dialysis patients: studies on mechanisms. Am J Nephrol 1991;11:102-11.
6. 2 consumption by PMNL from humans and rats with CRF: role of secondary hyperparathyroidism. Kidney Int 1992;42:602-9.
7. 7. Raine AE, Bedford L, Simpson AW, Ashley CC, Brown R, Woodhead JS, et al. Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure. Kidney Int 1993;43:700-5.
8. 2+]i and carboydrate metabolism of PMNL of dialysis patients. Kidney Int 1995;47:1741-5.
9. 2+]i and proliferation of B cells from dialysis patients. Kidney Int 1996;50:1249-54.
10. 10. Smogorzewski M, Koureta P, Fadda GZ, Perna F, Massry SG. Chronic parathyroid hormone excess in vivo increases resting levels of cytosolic calcium in brain synaptosomes: studies in the presence and absence of chronic renal failure. J Am Soc Nephrol 1991;1:1162-8.
11. 11. Fadda GZ, Thanakitcharu P, Smogorzewski M, Massry SG. Parathyroid hormone raises cytosolic calcium in pancreatic islets: study on mechanisms. Kidney Int 1993;43:554-60.
12. 12. Stojceva-Taneva O, Fadda GZ, Smogorzewski M, Massry SG. Parathyroid hormone increases cytosolic calcium of thymocytes. Nephron 1993;64:592-9.
13. 13. Smogorzewski M, Zayed M, Zhang YB, Roe J, Massry SG. Parathyroid hormone increases cytosolic calcium concentration in adult rat cardiac myocytcs. Am J Physiol 1993;264:H1998-2006.
14. 14. Massry SG, Smogorzewski M. The mechanisms responsible for the PTH-induced rise in cytosolic calcium in various cells are not uniform. Miner Electrolyte Metab 1995;21:13-28.
15. 2+]i and proliferation of B lymphoxytes of dialysis patients. Am J Kidney Dis 1997;29:233-8.
16. 16. Newberry WM, Sanford JP. Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum. J Clin Invest 1971;50:1262-71.
17. 17. Langhoff E, Ladefoged J, Odum N. Effect of interleukin-2 and methylprednisolone on in vitro transformation of uremic lymphocytes. Int Arch Allergy Appl Immunol 1986;81:5-11.
18. 18. Gelfand EW, Cheung RK, Grinstein S, Mills GB, Characterization of the role for calcium influx in mitogen-induced triggering of human T cells. Identification of calcium-dependent and calcium-independent signals. Eur J Immunol 1986;16:907-12.
19. 19. Gafter U, Malachi T, Ori Y, Breitbart H. The role of calcium in human lymphocyte DNA repair ability. J Lab Clin Med 1997;130:33-41.
20. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985;260:3440-50.
21. 21. Lichtman AH, Segel GB, Lichtman MA. Calcium transport and calcium-ATPase activity in human lymphocyte plasma membrane vesicles. J Biol Chem 1981;256:6148-54.
22. 22. Lowry OH, Rosenbrough NF, Farr AG, Randall RJ. Protein measurement with the Polin phenol reagent. J Biol Chem 1951;193:265-75.
23. 2+-ATPase activity in ram spermatozoa plasma membrane vesicles. Biochim Biophys Acta 1983;728:349-55.
24. 24. Breitbart H, Darshan R, Rubinstein S. Evidence for the presence of ATP-dependent calcium pump and ATPase activities in bull sperm head membranes. Biochem Biophys Res Commun 1984;122:479-84.
25. 2+ levels. Nature 1984;310:691-3.
26. 26. Emamghoreishi M, Schlichter L, Li PP, Parikh S, Sen J, Kamble A, et al. High intracellular calcium concentration in transformed lymphoblasts from subjects with bipolar 1 disorder. Am J Psychiatry 1997;154:976-82.
27. 27. June CH, Rabinovitch PS, Ledvetter JA. CD5 antibodies increase intracellular ionized calcium concentration in T cells. J Immunol 1987;138:2782-92.
28. 28. Pantaleo G, Olive D, Harris D, Poggi A, Moretta L, Moretta A. Signal transducing mechanisms involved in human T cell activation via surface T44 molecules. Comparison with signals transdeued via the T cell receptor complex. Eur J Immunol 1986;16:1693-42.
29. 29. Zweifach A, Lewis RS. Calcium-dependent potentiation of store-operated calcium channel in T lymphocytes. J Gen Physiol 1996;107:597-610.
30. 30. Hoth M, Penner R. Depletion of intracellular calcium stores activates calcium current in mast cells. Nature 1992;355:353-6.
31. 31. Miller RA. Accumulation of hyporesponsive, calcium extruding memory T cells as a key feature of age-dependent immune dysfunction. Clin Immunol Immunopathol 1991;58:305-17.
32. 32. Donnadieu E, Bismuth G, Trautmann A. Calcium fluxes in T lymphocytes. J Biol Chem 1992;267:25864-72.
33. 2+ exchange-mediated calcium entry in human lymphocytes. J Clin Invest 1994;94:2002-8.
34. 34. Yanagisawa H, Wada O. Significant increase of IQ-type heterocyclic amines in the plasma of patients with uremia, just before induction of hemodialysis treatment. Nephron 1989;52:6-10.
35. 35. Cohen G, Haag-Weber M, Horl WH. Immune dysfunction in uremia. Kidney Int 1997;62:S79-S82.
36. 36. Lauricella AM, Goldman HL, Massouh EJ, Nesse AB. Immunomodulatory activity of plasmatic substances. J Invest Allergol Clin Immunol 1991;1:341-6.
37. 37. Lindner A, Gagne ER, Zingraff J, Jungers P, Drucke TB, Hannaert P, et al. A circulating inhibitor of the RBC membrane calcium pump in chronic renal failure. Kidney Int 1992;42:1328-35.
38. 38. Zidek W, Rustemeyer T, Schulter W, Karas M, Kisters K, Gracfe U. Isolation of an ultrafilterable Ca(2+)-ATPase inhibitor from the plasma of uraemic patients. Clin Sci 1992;82:659-65.
39. 39. Lindner A, Vanholder R, De Smet R, Hinds TR, Vogeleere P, Sandra P, et al. HPLC fractions of human uremic plasma inhibit the RBC membrane calcium pump. Kidney Int 1997;51:1042-52.
40. 40. Whitney RB, Sutherland RM. Requirement for calcium ions in lymphocyte transformation stimulated by phytohemagglutinin. J Cell Physiol 1972;80:329-37.
41. 41. Kay JE. Interaction of lymphocytes and phytohemagglutinin: inhibition by chelating agents. Exp Cell Res 1971;68:11-6.
42. 42. Tsien RY, Pozzan T, Rink TJ. T cells mitogens cause early changes in cytoplasmic free Ca2+ and membrane potential in lymphocytes. Nature 1982;295:68-71.
43. 43. Hesketh TR, Smith GA, Moore JP, Taylor MV, Metcalfe JC. Free cytoplasmic calcium concentration and the mitogenic stimulation of lymphocytes. J Biol Chem 1983;258:4876-82.
44. 44. Gelfand EW, Cheung RK, Grinstein S. Role of membrane potential in the regulation of lectin-induced calcium uptake. J Cell Physiol 1984;121:533-9.
45. 45. Eckert A, Oster M, Forstl H, Hennerici M, Muller WE. Impaired calcium regulation in subcortical vascular encephalopathy. Stroke 1997;28:1351-6.
46. 46. Shurtz-Swirski R, Kristal B, Shkolnik T, Weissman I, Shapiro G, Shasha S. Short-term effect of erythropoietin on T-cell mitogenic proliferation in chronic renal failure patients. Nephron 1996;72:27-9.
47. 47. Wojcikiewicz RJ, Furuichi T, Nakade S, Mikoshiba K, Nahorski SR. Muscarinic receptor activation down-regualtes the type I inositol 1,4,5-trisphosphate receptor by accelerating its degradation. J Biol Chem 1994;269:7963-9.
48. 48. Isozki O, Emoto N, Tsushima T, Sato Y, Shizume K, Demuva H, et al. Opposite regualtion of deoxyribonucleic acid synthesis and iodide uptake in rat thyroid cells by basic fibroblast growth factor: correlation with opposite regulation of c′-fos and thyrotropin receptor gene expression. Endocrinology 1992;131:2723-32.
49. 49. Resink A, Villa M, Benke D, Hidaka H, Mohler H, Balazs R. Characterization of agonist-induced down-regulation of NMDA receptors in cerehellar granule cell cultures. J Neurochem 1996;66:369-77.